Summary of Study ST004537
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002861. The data can be accessed directly via it's Project DOI: 10.21228/M8VC3K This work is supported by NIH grant, U2C- DK119886. See: https://www.metabolomicsworkbench.org/about/howtocite.php
| Study ID | ST004537 |
| Study Title | C8 positive-mode LC–MS lipidomics of BMDM and PMN: WT vs KO (n=22) |
| Study Summary | We performed LC–MS lipidomics to quantify lipid remodeling associated with Tet2 KO in myeloid cells. Lipids were extracted from bone marrow–derived macrophages (BMDM; 7 WT and 7 KO replicates) and neutrophils/PMN (4 WT and 4 KO replicates) from murine bone marrow (BMDMD) or zymosan-induced peritoneum (PM) and analyzed using C8 reversed-phase liquid chromatography coupled to positive-ion electrospray mass spectrometry. This dataset includes raw LC–MS files (mzML and vendor raw) and processed lipid abundance tables used for the analyses reported in the associated manuscript “Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesis ”. |
| Institute | Harvard Medical School |
| Last Name | Kim |
| First Name | Peter Geon |
| Address | 360 Longwood Ave, LC8202 Boston, MA 02215 USA |
| gkim0@partners.org | |
| Phone | 6175254942 |
| Submit Date | 2026-01-08 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | mzML, raw(Thermo) |
| Analysis Type Detail | LC-MS |
| Release Date | 2026-01-16 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR002861 |
| Project DOI: | doi: 10.21228/M8VC3K |
| Project Title: | Lipidomics dataset for "Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesis" |
| Project Summary: | This project deposits LC–MS lipidomics raw and processed data supporting the manuscript "Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesis". Lipid profiles were measured using C8 reversed-phase chromatography and positive-ion MS in mouse macrophages annd neutrophils, comparing WT versus Tet2 KO. |
| Institute: | Harvard Medical School |
| Department: | Department of Medical Oncology at Dana Farber Cancer Institute |
| Laboratory: | Ebert |
| Last Name: | Peter Geon |
| First Name: | Kim |
| Address: | 360 Longwood Ave, LC8202 Boston, MA 02215 USA |
| Email: | gkim0@partners.org |
| Phone: | 6175254942 |
Subject:
| Subject ID: | SU004716 |
| Subject Type: | Mammal |
| Subject Species: | Mus musculus |
| Taxonomy ID: | 10090 |
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
| mb_sample_id | local_sample_id | Sample source | cell_type | genotype |
|---|---|---|---|---|
| SA537937 | BMDM_KO6 | BMDM | BMDM | KO |
| SA537938 | BMDM_KO2 | BMDM | BMDM | KO |
| SA537939 | BMDM_KO7 | BMDM | BMDM | KO |
| SA537940 | BMDM_KO1 | BMDM | BMDM | KO |
| SA537941 | BMDM_KO5 | BMDM | BMDM | KO |
| SA537942 | BMDM_KO3 | BMDM | BMDM | KO |
| SA537943 | BMDM_KO4 | BMDM | BMDM | KO |
| SA537944 | BMDM_WT7 | BMDM | BMDM | WT |
| SA537945 | BMDM_WT6 | BMDM | BMDM | WT |
| SA537946 | BMDM_WT5 | BMDM | BMDM | WT |
| SA537947 | BMDM_WT4 | BMDM | BMDM | WT |
| SA537948 | BMDM_WT3 | BMDM | BMDM | WT |
| SA537949 | BMDM_WT2 | BMDM | BMDM | WT |
| SA537950 | BMDM_WT1 | BMDM | BMDM | WT |
| SA537951 | PMN_KO2 | PMN | PMN | KO |
| SA537952 | PMN_KO3 | PMN | PMN | KO |
| SA537953 | PMN_KO4 | PMN | PMN | KO |
| SA537954 | PMN_KO1 | PMN | PMN | KO |
| SA537955 | PMN_WT1 | PMN | PMN | WT |
| SA537956 | PMN_WT2 | PMN | PMN | WT |
| SA537957 | PMN_WT3 | PMN | PMN | WT |
| SA537958 | PMN_WT4 | PMN | PMN | WT |
| Showing results 1 to 22 of 22 |
Collection:
| Collection ID: | CO004709 |
| Collection Summary: | For lipidomics or metabolomics experiments, mouse neutrophils were obtained from transplanted WT or Tet2 KO mice 4 weeks after transplantation, isolated 12 hours after zymosan 1mg i.p. injection using the neutrophil isolation kit (Miltenyi, 130-097-658). BMDMs were obtained from the bone marrow using differentiation method using MCSF 20ng/ml in DMEM / 10% FCS / PSG fforr 7-10 days |
| Sample Type: | Bone marrow |
Treatment:
| Treatment ID: | TR004725 |
| Treatment Summary: | Samples were generated from WT and conditional Tet2 knockout (KO) mice (Cre-lox model). Genotypes were determined by PCR-based genotyping, and Cre-mediated recombination status was confirmed per standard lab procedures. BMDMs and PMNs were prepared as described in the associated manuscript and BMDMs were collected under basal conditions from the bone marrow. PMNs were collected 12 hours after 1mg intraperitoneal zymosan injection using the Neutrophil Isolation Kit, mouse (Miltenyi). |
Sample Preparation:
| Sampleprep ID: | SP004722 |
| Sampleprep Summary: | Cell pellets were extracted for lipidomics using isopropanol containing 1,2-didodecanoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids) as an internal standard. Extracts were centrifuged and supernatants were injected for LC–MS analysis (C8 reversed-phase, positive-ion mode). |
Combined analysis:
| Analysis ID | AN007621 |
|---|---|
| Chromatography ID | CH005780 |
| MS ID | MS007318 |
| Analysis type | MS |
| Chromatography type | Reversed phase |
| Chromatography system | Shimadzu Nexera X2 |
| Column | Waters ACQUITY UPLC BEH C8 (100 x 2.1mm,1.7um) |
| MS Type | ESI |
| MS instrument type | Orbitrap |
| MS instrument name | Thermo Exactive Plus Orbitrap |
| Ion Mode | POSITIVE |
| Units | peak area (a.u.) |
Chromatography:
| Chromatography ID: | CH005780 |
| Instrument Name: | Shimadzu Nexera X2 |
| Column Name: | Waters ACQUITY UPLC BEH C8 (100 x 2.1mm,1.7um) |
| Column Temperature: | 40 |
| Flow Gradient: | 0–1 min: 80% A (20% B) isocratic; 1–3 min: linear to 80% B (20% A); 3–10 min: linear to 100% B; 10–13 min: hold 100% B |
| Flow Rate: | 450uL/min |
| Solvent A: | 95:5:0.1 vol/vol/vol 10mM ammonium acetate/methanol/formic acid |
| Solvent B: | 99.9:0.1 vol/vol methanol/formic acid |
| Chromatography Type: | Reversed phase |
MS:
| MS ID: | MS007318 |
| Analysis ID: | AN007621 |
| Instrument Name: | Thermo Exactive Plus Orbitrap |
| Instrument Type: | Orbitrap |
| MS Type: | ESI |
| MS Comments: | MS acquisition comments: Electrospray ionization (ESI) in positive mode; full-scan MS over m/z 200–1100 at 70,000 resolution with 3 Hz data acquisition. Sheath gas 50; sweep gas 5; in-source CID 5 eV; spray voltage 3 kV; capillary temperature 300°C; heater temperature 300°C; S-lens RF 60; microscans 1; AGC target 1e6; maximum ion time 100 ms. Data processing comments: Raw data were processed using Thermo TraceFinder for targeted peak integration with manual review of a subset of identified lipids, and Progenesis QI (Nonlinear Dynamics) for peak detection and integration of known and unknown lipids/features. Software/procedures used for feature assignments: Lipid identities were assigned by comparison to reference plasma extracts; lipids are denoted by total acyl-chain carbons and total double bonds |
| Ion Mode: | POSITIVE |